Plasma miR-142 predicts major adverse cardiovascular events as an intermediate biomarker of dual antiplatelet therapy
暂无分享,去创建一个
Ya‐Ling Han | Shi-long Zhong | C. Deng | H. Lei | Hong Wu | Qian-jie Tang | Xiao-hong Li | Ji-yan Chen | Wang-sheng Sheng | Yu-bi Lin | Yong-heng Fu
[1] Jie Du,et al. Circulating microRNA signature for the diagnosis of childhood dilated cardiomyopathy , 2018, Scientific Reports.
[2] Y. Zhang,et al. Suppression of microRNA-142-5p attenuates hypoxia-induced apoptosis through targeting SIRT7. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[3] Mingxin Zhang,et al. Down-regulation of microRNA-142-5p attenuates oxygen-glucose deprivation and reoxygenation-induced neuron injury through up-regulating Nrf2/ARE signaling pathway. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[4] Kota Shimada,et al. Plasma miRNA expression profiles in rheumatoid arthritis associated interstitial lung disease , 2017, BMC Musculoskeletal Disorders.
[5] G. Meister,et al. Transcriptomic profiling of platelet senescence and platelet extracellular vesicles , 2017, Transfusion.
[6] M. Mayr,et al. Association of MicroRNAs and YRNAs With Platelet Function. , 2016, Circulation research.
[7] V. Figueredo,et al. Dipstick proteinuria is an independent predictor of high on treatment platelet reactivity in patients on clopidogrel, but not aspirin, admitted for major adverse cardiovascular events , 2015, Platelets.
[8] Wen-jie Ji,et al. The Emerging Role of miR-223 in Platelet Reactivity: Implications in Antiplatelet Therapy , 2015, BioMed research international.
[9] Nilesh J Samani,et al. MicroRNAs in cardiovascular disease: an introduction for clinicians , 2015, Heart.
[10] Weiqing Wang,et al. Elevated circulating microRNA-122 is associated with obesity and insulin resistance in young adults. , 2015, European journal of endocrinology.
[11] D. Voora,et al. Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics , 2015, Pharmacogenomics and personalized medicine.
[12] M. Trivella,et al. Differential Regulation of MicroRNAs in End-Stage Failing Hearts Is Associated with Left Ventricular Assist Device Unloading , 2015, BioMed research international.
[13] Lin Wang,et al. Upregulation of miR-142-5p in atherosclerotic plaques and regulation of oxidized low-density lipoprotein-induced apoptosis in macrophages , 2015, Molecular medicine reports.
[14] Qiu-lin Tang,et al. Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer. , 2014, Oncology reports.
[15] A. Siegbahn,et al. ROLE OF ADMISSION CARDIAC BIOMARKERS IN RISK STRATIFICATION OF PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE PLATELET INHIBITION AND PATIENT OUTCOMES TRIAL , 2014 .
[16] M. Jeong,et al. B cell translocation gene, a direct target of miR‐142‐5p, inhibits vascular smooth muscle cell proliferation by down‐regulating cell cycle progression , 2013, FEBS letters.
[17] M. Mayr,et al. Circulating MicroRNAs as Novel Biomarkers for Platelet Activation , 2013 .
[18] Salil Sharma,et al. Repression of miR-142 by p300 and MAPK is required for survival signalling via gp130 during adaptive hypertrophy , 2012, EMBO molecular medicine.
[19] M. Tewari,et al. MicroRNA profiling: approaches and considerations , 2012, Nature Reviews Genetics.
[20] Jun Luo,et al. Identification of circulating miRNA biomarkers based on global quantitative real-time PCR profiling , 2012, Journal of Animal Science and Biotechnology.
[21] C. Cannon,et al. Association of Proton Pump Inhibitor Use on Cardiovascular Outcomes With Clopidogrel and Ticagrelor: Insights From the Platelet Inhibition and Patient Outcomes Trial , 2012, Circulation.
[22] Deepak L. Bhatt,et al. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. , 2010, Journal of the American College of Cardiology.
[23] S. Shenouda,et al. MicroRNA function in cancer: oncogene or a tumor suppressor? , 2009, Cancer and Metastasis Reviews.
[24] R. Koppensteiner,et al. Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition , 2009, Heart.
[25] Monika Belickova,et al. Differential expression of microRNAs in hematopoietic cell lineages , 2008, European journal of haematology.
[26] C. Sander,et al. A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.
[27] D. Atar,et al. Assessment of bleeding events in clinical trials--proposal of a new classification. , 2007, The American journal of cardiology.
[28] Eugene Berezikov,et al. Approaches to microRNA discovery , 2006, Nature Genetics.
[29] D. Bartel,et al. MicroRNAs Modulate Hematopoietic Lineage Differentiation , 2004, Science.
[30] S. Yusuf,et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. , 2001, The New England journal of medicine.
[31] S. Zhong,et al. Catheter ablation restores decreased plasma miR-409-3p and miR-432 in atrial fibrillation patients. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.